Topic guide

Weight loss

Evidence checks about obesity, GLP-1 drugs, diets, fasting, fat-loss claims, supplements and metabolic headlines.

What to watch for

Common ways headlines can go too far

  • Short-term weight change framed as durable benefit
  • Trial populations generalised too widely
  • Benefits reported without side-effect or stopping context

Weight-loss headlines often overstate early drug, diet or supplement findings without enough context about durability, side effects, adherence or who was studied.

Common hype patterns

  • Short-term weight change framed as durable health benefit.
  • Drug-trial results generalised beyond the studied population.
  • Before-and-after claims used without controlled evidence.
  • Benefits reported without harms, cost, stopping or regain context.

Questions to ask before trusting the headline

  • Was the claim tested in people, or only in cells, animals or models?
  • Is the outcome something patients notice, or only a surrogate marker?
  • Does the headline distinguish association from causation?
  • Are absolute risks, comparators and uncertainty shown clearly?
  • Would the finding change real-world behaviour, or is it mainly hypothesis-generating?

How deHype.io reads this topic

deHype.io separates the public claim from the underlying evidence. The aim is not to dismiss early science, but to show whether the headline has kept the finding in proportion.

Seen a headline in this topic? Paste the link and get a deHype evidence check.
Check a weight-loss headline